Try our Advanced Search for more refined results
Searching dockets in Takeda Pharmaceutical Co Ltd x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Patent | New Jersey
Appear Pro Hac Vice
Consent MOTION for Leave to Appear Pro Hac Vice by TAKEDA PHARMACEUTICALS INTERNATIONAL AG, TAKEDA PHARMACEUTICALS USA, INC.. (Attachments: # 1 Proposed Order, # 2 Certification of Harvey Bartle, # 3 Certification of Michael Abernathy, # 4 Certification of Christopher Bettis, # 5 Certification of Christian Boettcher, # 6 Certification of Maria Doukas, # 7 Certification of Julie Goldemberg, # 8 Certification of Anna Johnson, # 9 Certification of Wan-Shon Lo, # 10 Certification of Margaret McGreal, # 11 Certification of Michael Sikora, # 12 Certification of Amanda Williamson)(BARTLE, HARVEY)
P.I.: Other | North Carolina Eastern
Response in Opposition to Motion
RESPONSE in Opposition regarding 120 MEMORANDUM AND RECOMMENDATIONS regarding 53 MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM filed by BASF Corporation Opposition to BASF Objection to D.E. 120 filed by Lydia Diane Brock, Roy Brock. (DuPont, Andrew)
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
Phone
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 UK may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.